June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Effect of Interleukin-6 Inhibition in a Rodent Model of Non-Arteritic Anterior Ischemic Optic Neuropathy
Author Affiliations & Notes
  • Amanda D Henderson
    Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Yan Guo
    Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Zara Mehrabyan
    Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Mary A Johnson
    Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Neil R Miller
    Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Steven L Bernstein
    Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Amanda Henderson, None; Yan Guo, None; Zara Mehrabyan, None; Mary Johnson, None; Neil Miller, None; Steven Bernstein, None
  • Footnotes
    Support  NEI RO1EY015304
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 2403. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Amanda D Henderson, Yan Guo, Zara Mehrabyan, Mary A Johnson, Neil R Miller, Steven L Bernstein; Effect of Interleukin-6 Inhibition in a Rodent Model of Non-Arteritic Anterior Ischemic Optic Neuropathy. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2403.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Non-arteritic anterior ischemic optic neuropathy (NAION) is the most common acute optic nerve-related cause of vision loss in people over age 50; however, NAION has no proven treatment. Previously, we demonstrated that interleukin-6 (IL-6) is upregulated in an experimental rodent model of NAION (rNAION), based on deep sequencing data from rat optic nerve and retinal tissue. In this experiment, we tested the hypothesis that IL-6 inhibition would decrease inflammatory response and preserve retinal ganglion cells (RGCs) in the rNAION model.

Methods : rNAION was induced in 4 adult male Sprague-Dawley rats. On post-induction day 1, optic nerve edema was assessed by slit lamp and optical coherence tomography (OCT), and animals were paired in terms of similar amounts of edema. One from each pair was treated with subcutaneous sarilumab (human IL-6 inhibitor), whereas the others received vehicle (saline). At 1 week post-induction, rats were euthanized, and eyes and optic nerves were isolated and post-fixed in 4% paraformaldehyde-PBS. Post-fixed retinas were isolated, and RGCs immunostained with Brn3a antibody. Cryopreserved optic nerve laminar sections were immunostained with Iba1 (for microglia), CD68 (for macrophages), and SMI312 (for neurofilaments).

Results : There was no appreciable reduction in resident microglia or extrinsic macrophage recruitment (Figure 1) and no appreciable RGC preservation (Figure 2) in rNAION animals treated with sarilumab compared with controls.

Conclusions : IL-6 inhibition does not appear to reduce inflammatory cell recruitment or to preserve RGCs in rNAION, when administered 1 day after disease-state induction, despite known IL-6 upregulation in this disease model. Possible explanations for this finding include (1) a narrow time window for therapeutic anti-inflammatory treatment in rNAION, in which case this treatment avenue is not likely to be clinically relevant; (2) the IL-6 response is a nonspecific inflammatory epiphenomenon and may not specifically modulate damage-inducing inflammation in rNAION; or (3) the fully humanized sarilumab antibody is functionally limited in its effects in rat. Further study with a rodentized IL-6 inhibitor may further elucidate the role of IL-6 inhibition in rNAION.

This is a 2021 ARVO Annual Meeting abstract.

 

Iba1 (microglia) and CD68 (macrophages) immunostaining in lamina cross sections from rNAION

Iba1 (microglia) and CD68 (macrophages) immunostaining in lamina cross sections from rNAION

 

SMI 312 neurofibrillar immunostaining in lamina cross sections from rNAION

SMI 312 neurofibrillar immunostaining in lamina cross sections from rNAION

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×